MedTrace Logo

Survey Study About Endoscopy During COVID-19 Pandemic for IBD Doctors

NCT04970849 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-07-21

No results posted yet for this study

Summary

Performance of diagnostic or therapeutic endoscopic procedures in inflammatory bowel disease (IBD) patients can be challenging during a viral pandemic; the main concerns being the safety and protection of patients and health care providers (HCP). The aim of this study is to identify endoscopic practice patterns and outcomes of IBD and coronavirus disease 19 (COVID-19) with a worldwide survey of HCP.

Conditions

  • Inflammatory Bowel Diseases

Interventions

OTHER

observation

IBD doctors who perform the endoscopy perform the questionnaire

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Yan Chen · 浙江大学医学院附属第二医院

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-15
Primary Completion
2021-07-15
Completion
2021-07-15
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04970849 on ClinicalTrials.gov